Bromocriptine mesylate and Hyperhidrosis - a phase IV clinical study of FDA data

Summary:

Hyperhidrosis is reported as a side effect among people who take Bromocriptine mesylate (bromocriptine mesylate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Bisacodyl, and have Parkinson's disease.

The phase IV clinical study analyzes which people have Hyperhidrosis when taking Bromocriptine mesylate. It is created by eHealthMe based on reports of 918 people who have side effects when taking Bromocriptine mesylate from the FDA, and is updated regularly.

What is Bromocriptine mesylate?

Bromocriptine mesylate has active ingredients of bromocriptine mesylate. It is often used in prolactinoma. eHealthMe is studying from 1,011 Bromocriptine mesylate users. Check the latest studies of Bromocriptine mesylate.

What is Hyperhidrosis?

Hyperhidrosis (abnormally increased sweating) is found to be associated with 2,551 drugs and 3,546 conditions by eHealthMe. Check the latest studies of Hyperhidrosis.

On Jul, 09, 2026

918 people reported to have side effects when taking Bromocriptine mesylate.
Among them, 12 people (1.31%) have Hyperhidrosis.

Could Bromocriptine mesylate cause Hyperhidrosis?

Among these 12 people:

How long have people been on Bromocriptine mesylate when they have Hyperhidrosis? *

What is the gender of people who have Hyperhidrosis when taking Bromocriptine mesylate? *

female: 41.67 %
male: 58.33 %

What is the age of people who have Hyperhidrosis when taking Bromocriptine mesylate? *

What are other drugs people take besides Bromocriptine mesylate? *

What are other side effects people have besides Hyperhidrosis? *

Muscle Rigidity (muscle stiffness): 7 people, 58.33%
Neuroleptic Malignant Syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents): 6 people, 50.00%
Fever: 5 people, 41.67%
Blood Creatine Phosphokinase Increased: 5 people, 41.67%
Agitation (state of anxiety or nervous excitement): 4 people, 33.33%
Nausea (feeling of having an urge to vomit): 3 people, 25.00%
Blood Lactate Dehydrogenase Increased: 3 people, 25.00%
High Blood Pressure: 3 people, 25.00%
Sinus Tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node): 3 people, 25.00%
Hypotension (abnormally low blood pressure): 3 people, 25.00%

What are the existing conditions these people have? *

Parkinson's Disease: 4 people, 33.33%
Prolactin-Producing Pituitary Tumor: 1 person, 8.33%
Productive Cough: 1 person, 8.33%
Osteoporosis (bones weak and more likely to break): 1 person, 8.33%
Gastrointestinal Hypomotility (less activity of the intestinal tract): 1 person, 8.33%
Depression: 1 person, 8.33%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 8.33%
Breast Cancer: 1 person, 8.33%
Bone Pain: 1 person, 8.33%
Back Pain: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Bromocriptine mesylate and have Hyperhidrosis?

- Check whether Hyperhidrosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bromocriptine mesylate:

Bromocriptine mesylate (1,011 reports)

Hyperhidrosis treatments and more:

Hyperhidrosis (147,206 reports)

Browse all side effects of Bromocriptine mesylate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperhidrosis:

Hyperhidrosis (2,551 drugs)

Browse all the conditions that are associated with Hyperhidrosis:

Hyperhidrosis (3,546 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bromocriptine mesylate (the active ingredients of Bromocriptine mesylate) and Bromocriptine mesylate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.